These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36992217)

  • 1. Projection of COVID-19 Positive Cases Considering Hybrid Immunity: Case Study in Tokyo.
    Kodera S; Takada A; Rashed EA; Hirata A
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-Level Immunity for Transient Suppression of COVID-19 Waves in Japan from April 2021 to September 2022.
    Kodera S; Ueta H; Unemi T; Nakata T; Hirata A
    Vaccines (Basel); 2023 Sep; 11(9):. PubMed ID: 37766133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia.
    MacIntyre CR; Costantino V; Trent M
    Vaccine; 2022 Apr; 40(17):2506-2513. PubMed ID: 33958223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of age structure and vaccine prioritization on COVID-19 in West Africa.
    Taboe HB; Asare-Baah M; Yesmin A; Ngonghala CN
    Infect Dis Model; 2022 Dec; 7(4):709-727. PubMed ID: 36097593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of mRNA COVID-19 Vaccination Effectiveness in Tokyo for Omicron Variants BA.2 and BA.5: Effect of Social Behavior.
    Kodera S; Niimi Y; Rashed EA; Yoshinaga N; Toyoda M; Hirata A
    Vaccines (Basel); 2022 Oct; 10(11):. PubMed ID: 36366329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccine strategies for Aotearoa New Zealand: a mathematical modelling study.
    Nguyen T; Adnan M; Nguyen BP; de Ligt J; Geoghegan JL; Dean R; Jefferies S; Baker MG; Seah WK; Sporle AA; French NP; Murdoch DR; Welch D; Simpson CR
    Lancet Reg Health West Pac; 2021 Oct; 15():100256. PubMed ID: 34426804
    [No Abstract]   [Full Text] [Related]  

  • 9. Herd immunity induced by COVID-19 vaccination programs and suppression of epidemics caused by the SARS-CoV-2 Delta variant in China.
    Liu H; Zhang J; Cai J; Deng X; Peng C; Chen X; Yang J; Wu Q; Chen X; Chen Z; Zheng W; Viboud C; Zhang W; Ajelli M; Yu H
    medRxiv; 2021 Sep; ():. PubMed ID: 34341803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Projecting influenza vaccine effectiveness: A simulation study.
    Vilches TN; Shoukat A; Ferreira CP; Moghadas SM
    PLoS One; 2020; 15(11):e0241549. PubMed ID: 33141871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The estimated impact of natural immunity on the effectiveness of human papillomavirus vaccination.
    Matthijsse SM; Hontelez JAC; Naber SK; van Rosmalen J; Rozemeijer K; Penning C; Bakker R; van Ballegooijen M; de Kok IMCM; de Vlas SJ
    Vaccine; 2015 Oct; 33(41):5357-5364. PubMed ID: 26348405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A country-specific model of COVID-19 vaccination coverage needed for herd immunity in adult only or population wide vaccination programme.
    Goh FT; Chew YZ; Tam CC; Yung CF; Clapham H
    Epidemics; 2022 Jun; 39():100581. PubMed ID: 35636311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation using dynamic transition modeling of ebola virus vaccination in lower-and-middle-income countries.
    Obeng-Kusi M; Habila MA; Roe DJ; Erstad B; Abraham I
    J Med Econ; 2021 Nov; 24(sup1):1-13. PubMed ID: 34866541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. R
    Elsaid M; Nasef MA; Huy NT
    Hum Vaccin Immunother; 2021 Nov; 17(11):3850-3854. PubMed ID: 34612165
    [No Abstract]   [Full Text] [Related]  

  • 15. Population-Weighted Seroprevalence From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, Vaccination, and Hybrid Immunity Among US Blood Donations From January to December 2021.
    Busch MP; Stramer SL; Stone M; Yu EA; Grebe E; Notari E; Saa P; Ferg R; Manrique IM; Weil N; Fink RV; Levy ME; Green V; Cyrus S; Williamson PC; Haynes J; Groves J; Krysztof D; Custer B; Kleinman S; Biggerstaff BJ; Opsomer JD; Jones JM
    Clin Infect Dis; 2022 Oct; 75(Suppl 2):S254-S263. PubMed ID: 35684973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Meningococcal Vaccination Among Men Who Have Sex With Men in New York City.
    Simon MS; Weiss D; Geevarughese A; Kratz MM; Cutler B; Gulick RM; Zucker JR; Varma JK; Schackman BR
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):146-54. PubMed ID: 26334735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling the effect of the vaccination campaign on the COVID-19 pandemic.
    Angeli M; Neofotistos G; Mattheakis M; Kaxiras E
    Chaos Solitons Fractals; 2022 Jan; 154():111621. PubMed ID: 34815624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
    PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectivity Upsurge by COVID-19 Viral Variants in Japan: Evidence from Deep Learning Modeling.
    Rashed EA; Hirata A
    Int J Environ Res Public Health; 2021 Jul; 18(15):. PubMed ID: 34360092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid Immunity for COVID-19 in Bolivian Healthcare Workers.
    Copana Olmos R; Guillen Rocha N; Mamani Y; Rodriguez Alvarez G; Ovando Campos A; Camacho Tufiño C
    Cureus; 2022 Jul; 14(7):e27449. PubMed ID: 36051711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.